Patent application number | Description | Published |
20080202075 | Layered Film Compositions, Packages Prepared Therefrom, and Methods of Use - The invention relates to a perforated film composition, comprising at least three layers, and wherein at least one layer is a inner layer with a softening and/or melting temperature, lower than the respective softening and/or melting temperatures of at least two outer layers, located at opposite surfaces of the inner layer, and where upon exposure to elevated temperature, the inner layer softens or melts to such an extent, that upon exposure to a compression force, a sufficient number of perforations seal in the inner layer, to impart an increased moisture barrier to the overall film composition. The invention also relates to a method of forming such a perforated film composition, packages prepared from the same, and a method of filling packages prepared from the perforated film composition. | 08-28-2008 |
20090286013 | USE OF MICROWAVE ENERGY TO SELECTIVELY HEAT THERMOPLASTIC POLYMER SYSTEMS - A method for processing a thermoplastic material that comprises a microwave-sensitive polymeric region, wherein the method includes exposing the microwave-sensitive polymeric region to microwaves; wherein the exposing results in an increase in the temperature of the polymeric region; and processing the thermoplastic material is disclosed. | 11-19-2009 |
20130288016 | MICROCAPILLARY FILMS AND FOAMS CONTAINING FUNCTIONAL FILLER MATERIALS - The instant invention provides microcapillary films and/or foams containing one or more functional filler materials. The inventive microcapillary film or foam containing one or more functional filler materials according to the present invention has a first end and a second end, and comprises: (a) a matrix comprising a thermoplastic material, (b) at least one or more channels disposed in parallel in said matrix from the first end to the second end of said microcapillary film, wherein said one or more channels are at least 1 μm apart from each other, and wherein each said one or more channels have a diameter in the range of at least 1 μm; and (c) at least one or more functional filler materials disposed in said one or more channels; wherein said microcapillary film has a thickness in the range of from 2 μm to 2000 μm. | 10-31-2013 |
20140072776 | REINFORCED MICROCAPILLARY FILMS AND FOAMS - The instant invention provides reinforced microcapillary films and/or foams. The inventive reinforced film and/or foam have a first end and a second end, wherein the film and/or foam comprises: (a) a matrix comprising a first thermoplastic material, (b) at least one or more channels disposed in parallel in said matrix from the first end to the second end of the film or foam, wherein said one or more channels are at least 1 μm apart from each other, and wherein each said one or more channels have a diameter in the range of at least 1 μm; and (c) a second thermoplastic material disposed in said one or more channels, wherein said second thermoplastic material is different than the first thermoplastic material; wherein said film has a thickness in the range of from 2 μm to 2000 μm. | 03-13-2014 |
Patent application number | Description | Published |
20080287397 | Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group - An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. This problem can be solved with a pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by formula [I] below which has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. | 11-20-2008 |
20110130364 | PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP - An object of the present invention is to provide an antagonist against CRF receptors which is effective as a therapeutic or prophylactic agent for diseases in which CRF is considered to be involved, such as depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastric diseases, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, cephalic external wound, inflammation, immunity-related diseases, alopecia, irritable bowel syndrome, sleep disorders, epilepsy, dermatitides, schizophrenia, etc. This problem can be solved with a pyrrolopyrimidine or pyrrolopyridine derivative substituted with a cyclic amino group represented by formula [I] below which has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. | 06-02-2011 |
Patent application number | Description | Published |
20090030039 | Piperidine Derivatives as Cxcr3 Receptor Antagonists - The present invention relates to a compound of formula (I) | 01-29-2009 |
20100184776 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula (I) including any stereochemically isomeric form thereof, wherein A represents CH or N; X represents O or NR | 07-22-2010 |
20100190789 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula (I): including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —C(═O)—; —O—C(═O)—; C(═O)—C(═O)—; —NR | 07-29-2010 |
20100216809 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention further relates to a DGAT inhibitor of formula (I), including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —NR | 08-26-2010 |
20130102777 | PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2--ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]- -[2]-BENZAZEPINE-10-CARBOXYLIC ACID - The present invention relates to an improved method for the preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid. The present invention also relates to a new compound, namely tert-butyl (methyl-{2-[2-(methylamino)-ethoxy]-ethyl}-sulphamoyl)-carbamate, used in this improved method. | 04-25-2013 |
20140046072 | PROCESS FOR THE PREPARATION OF HETEROCYCLIC ESTER DERIVATIVES - The present invention is directed to a process for the preparation of heterocyclic ester derivatives of formula I | 02-13-2014 |
20140350012 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention further relates to a DGAT inhibitor of formula | 11-27-2014 |
20150087629 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula | 03-26-2015 |
20150322088 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention further relates to a DGAT inhibitor of formula | 11-12-2015 |
20150329482 | Preparation of 13-Cyclohexyl-3-Methoxy-6-[Methyl-(2-(2-[Methyl-(Sulphamoyl)-Amino]-Ethox- y}-Ethyl)-Carbamoyl]-7H-Indolo-{2,1-a]-[2]-Benzazepine-10-Carboxylic Acid - The present invention relates to an improved method for the preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid. The present invention also relates to a new compound, namely tent-butyl (methyl-{2-[2-(methylamino)-ethoxy]-ethyl}-sulphamoyl)-carbamate, used in this improved method. | 11-19-2015 |
20160081997 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula | 03-24-2016 |